Being cheaper and easier to maintain – therefore, also to transport – are two of the advantages associated with the Oxford / AstraZeneca vaccine against covid-19, whose approval the UK announced this Wednesday. Considered a powerful ally of the vaccination program in the country and the great hope for global vaccination, its development has also followed a different path from the process used by both Pfizer / BioNTech and Moderna.
–
